

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.57658498 |
| 2 | vocalization behavior (GO:0071625) | 5.54075291 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.53648282 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.46112757 |
| 5 | glutamate secretion (GO:0014047) | 5.41245617 |
| 6 | protein localization to synapse (GO:0035418) | 5.31592141 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.27361285 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.22695911 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.07126932 |
| 10 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 5.03486909 |
| 11 | axonal fasciculation (GO:0007413) | 5.01512436 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.86143401 |
| 13 | presynaptic membrane assembly (GO:0097105) | 4.84015986 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.75933184 |
| 15 | neuron recognition (GO:0008038) | 4.75041793 |
| 16 | presynaptic membrane organization (GO:0097090) | 4.71491876 |
| 17 | synaptic vesicle maturation (GO:0016188) | 4.69643027 |
| 18 | positive regulation of synapse maturation (GO:0090129) | 4.67094948 |
| 19 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.66375193 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.63186756 |
| 21 | postsynaptic membrane organization (GO:0001941) | 4.60270252 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 4.57866284 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.57857439 |
| 24 | exploration behavior (GO:0035640) | 4.54646586 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52995861 |
| 26 | myelination in peripheral nervous system (GO:0022011) | 4.44993065 |
| 27 | peripheral nervous system axon ensheathment (GO:0032292) | 4.44993065 |
| 28 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.25759846 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 4.17575908 |
| 30 | cell migration in hindbrain (GO:0021535) | 4.11024208 |
| 31 | regulation of axon extension involved in axon guidance (GO:0048841) | 4.09442083 |
| 32 | atrial cardiac muscle cell action potential (GO:0086014) | 4.09227798 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.06217225 |
| 34 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.01448451 |
| 35 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.99230502 |
| 36 | response to nerve growth factor (GO:1990089) | 3.99230502 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 3.98730457 |
| 38 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.93944617 |
| 39 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.92939704 |
| 40 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91631245 |
| 41 | regulation of axon guidance (GO:1902667) | 3.91277168 |
| 42 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.84192718 |
| 43 | regulation of synaptic vesicle transport (GO:1902803) | 3.83194036 |
| 44 | limb bud formation (GO:0060174) | 3.82889643 |
| 45 | cerebral cortex cell migration (GO:0021795) | 3.82643305 |
| 46 | glutamate receptor signaling pathway (GO:0007215) | 3.82625885 |
| 47 | dendrite morphogenesis (GO:0048813) | 3.77727628 |
| 48 | synaptic transmission, glutamatergic (GO:0035249) | 3.76833960 |
| 49 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.74427770 |
| 50 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.73906728 |
| 51 | central nervous system neuron axonogenesis (GO:0021955) | 3.67747059 |
| 52 | positive regulation of dendrite morphogenesis (GO:0050775) | 3.63869545 |
| 53 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60665550 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.56044660 |
| 55 | regulation of synapse maturation (GO:0090128) | 3.54075030 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.54004885 |
| 57 | short-term memory (GO:0007614) | 3.51002250 |
| 58 | regulation of dendritic spine development (GO:0060998) | 3.50987440 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.44211432 |
| 60 | proline transport (GO:0015824) | 3.42741860 |
| 61 | nucleobase catabolic process (GO:0046113) | 3.42394409 |
| 62 | regulation of heat generation (GO:0031650) | 3.40501345 |
| 63 | sympathetic nervous system development (GO:0048485) | 3.40378671 |
| 64 | positive regulation of membrane potential (GO:0045838) | 3.40007457 |
| 65 | regulation of sarcomere organization (GO:0060297) | 3.39814185 |
| 66 | astrocyte development (GO:0014002) | 3.38265765 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.36809731 |
| 68 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.33787736 |
| 69 | establishment of mitochondrion localization (GO:0051654) | 3.33716575 |
| 70 | regulation of synaptic plasticity (GO:0048167) | 3.33496236 |
| 71 | regulation of neurotransmitter secretion (GO:0046928) | 3.33070125 |
| 72 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.33024621 |
| 73 | neuronal action potential propagation (GO:0019227) | 3.30829804 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.30643360 |
| 75 | neurotransmitter secretion (GO:0007269) | 3.30560816 |
| 76 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.29192765 |
| 77 | positive regulation of muscle hypertrophy (GO:0014742) | 3.29192765 |
| 78 | regulation of synapse structural plasticity (GO:0051823) | 3.26462043 |
| 79 | mitochondrion transport along microtubule (GO:0047497) | 3.26045896 |
| 80 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.26045896 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.25360965 |
| 82 | protein localization to endosome (GO:0036010) | 3.25308976 |
| 83 | positive regulation of potassium ion transport (GO:0043268) | 3.21424290 |
| 84 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.19335196 |
| 85 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.14880709 |
| 86 | dendritic spine organization (GO:0097061) | 3.14848170 |
| 87 | membrane depolarization during action potential (GO:0086010) | 3.14095310 |
| 88 | axon extension (GO:0048675) | 3.11662084 |
| 89 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.09156926 |
| 90 | ephrin receptor signaling pathway (GO:0048013) | 3.06773085 |
| 91 | cochlea development (GO:0090102) | 3.06684953 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.06568674 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.06325122 |
| 94 | positive regulation of synapse assembly (GO:0051965) | 3.06124421 |
| 95 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.03559153 |
| 96 | long-term memory (GO:0007616) | 3.02307015 |
| 97 | establishment of nucleus localization (GO:0040023) | 2.99938186 |
| 98 | cardiac ventricle formation (GO:0003211) | 2.99516330 |
| 99 | regulation of synapse assembly (GO:0051963) | 2.98381198 |
| 100 | auditory behavior (GO:0031223) | 2.97305748 |
| 101 | positive regulation of dendrite development (GO:1900006) | 2.94468186 |
| 102 | neuron projection extension (GO:1990138) | 2.94366419 |
| 103 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.93933060 |
| 104 | anatomical structure arrangement (GO:0048532) | 2.93460091 |
| 105 | dendrite development (GO:0016358) | 2.92644733 |
| 106 | regulation of synapse organization (GO:0050807) | 2.91470971 |
| 107 | C4-dicarboxylate transport (GO:0015740) | 2.90747336 |
| 108 | synapse assembly (GO:0007416) | 2.90467138 |
| 109 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.90422928 |
| 110 | cranial nerve morphogenesis (GO:0021602) | 2.90210183 |
| 111 | organelle transport along microtubule (GO:0072384) | 2.90065425 |
| 112 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.89359180 |
| 113 | behavioral defense response (GO:0002209) | 2.88439707 |
| 114 | behavioral fear response (GO:0001662) | 2.88439707 |
| 115 | membrane assembly (GO:0071709) | 2.87832253 |
| 116 | response to histamine (GO:0034776) | 2.87631731 |
| 117 | regulation of vesicle fusion (GO:0031338) | 2.87106078 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.86722143 |
| 119 | positive regulation of neurotransmitter transport (GO:0051590) | 2.85699845 |
| 120 | gamma-aminobutyric acid transport (GO:0015812) | 2.84147521 |
| 121 | cranial nerve structural organization (GO:0021604) | 2.82969411 |
| 122 | facial nerve structural organization (GO:0021612) | 2.80580031 |
| 123 | regulation of neurotransmitter transport (GO:0051588) | 2.80500051 |
| 124 | response to pheromone (GO:0019236) | 2.80354786 |
| 125 | fear response (GO:0042596) | 2.79830633 |
| 126 | mechanosensory behavior (GO:0007638) | 2.79782641 |
| 127 | negative regulation of neurotransmitter transport (GO:0051589) | 2.77162024 |
| 128 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.77046197 |
| 129 | synapse organization (GO:0050808) | 2.76291371 |
| 130 | regulation of dendrite development (GO:0050773) | 2.74880094 |
| 131 | negative regulation of axonogenesis (GO:0050771) | 2.74707987 |
| 132 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.74457822 |
| 133 | innervation (GO:0060384) | 2.73853744 |
| 134 | learning (GO:0007612) | 2.72855024 |
| 135 | telencephalon cell migration (GO:0022029) | 2.71050202 |
| 136 | regulation of dendrite morphogenesis (GO:0048814) | 2.70800125 |
| 137 | neurotransmitter transport (GO:0006836) | 2.70753235 |
| 138 | cell communication involved in cardiac conduction (GO:0086065) | 2.70585743 |
| 139 | cardiac chamber formation (GO:0003207) | 2.70497440 |
| 140 | startle response (GO:0001964) | 2.67915444 |
| 141 | mitochondrial genome maintenance (GO:0000002) | 2.67693677 |
| 142 | sodium ion export (GO:0071436) | 2.67563423 |
| 143 | negative regulation of dendrite development (GO:2000171) | 2.67401702 |
| 144 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.66107406 |
| 145 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.64118057 |
| 146 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.63545028 |
| 147 | forebrain cell migration (GO:0021885) | 2.63353894 |
| 148 | membrane depolarization (GO:0051899) | 2.62122145 |
| 149 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61727109 |
| 150 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.61315021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.09749417 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77267415 |
| 3 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95667985 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.95170502 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81371742 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.67617470 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.65996011 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58461390 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58461390 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48801039 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46371518 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.44914590 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41915263 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36719723 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35927591 |
| 16 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20228653 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18997927 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.17778564 |
| 19 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.17384517 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14915844 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11957369 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.06612815 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03703403 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99712506 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98200014 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94150789 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.92651454 |
| 28 | * SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.84865779 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84757935 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81234448 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78454188 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.77187104 |
| 33 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.75567747 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75026627 |
| 35 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.72857315 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.65984746 |
| 37 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.65101556 |
| 38 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.64338970 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62136970 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61271309 |
| 41 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60528087 |
| 42 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.59577246 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57965374 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56401600 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.56186945 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53715896 |
| 47 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52427143 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.51488616 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45608559 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44358507 |
| 51 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43994830 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42937245 |
| 53 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42032146 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41316595 |
| 55 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39316149 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37899564 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37714783 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34866136 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33293874 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.32809083 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.32800563 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.32800563 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32796676 |
| 64 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32399213 |
| 65 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32306707 |
| 66 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.28931219 |
| 67 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.28353245 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28253969 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28207305 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28207305 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27582821 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26459600 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26158751 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25565750 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25462321 |
| 76 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24225602 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23712564 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23495767 |
| 79 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.22304997 |
| 80 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22043428 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20513615 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20201043 |
| 83 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19856019 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19856019 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18867221 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18617918 |
| 87 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16077652 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15600812 |
| 89 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14693935 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14435635 |
| 91 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14150083 |
| 92 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13662578 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13492063 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13109356 |
| 95 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.11223401 |
| 96 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11078958 |
| 97 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.10941311 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10762019 |
| 99 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10547338 |
| 100 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09581917 |
| 101 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09178737 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08858932 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07776873 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07513312 |
| 105 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07012409 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05781321 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02910999 |
| 108 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02673797 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02547622 |
| 110 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01773615 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01555060 |
| 112 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01141463 |
| 113 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01138203 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 1.00340920 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99244345 |
| 116 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96854221 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96596862 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95694707 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93693435 |
| 120 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93568741 |
| 121 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93517837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.14878230 |
| 2 | MP0003880_abnormal_central_pattern | 4.74808968 |
| 3 | MP0004270_analgesia | 4.07802415 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.67921358 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.18313229 |
| 6 | MP0004043_abnormal_pH_regulation | 3.15030523 |
| 7 | MP0000778_abnormal_nervous_system | 3.02684703 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.76160466 |
| 9 | MP0009745_abnormal_behavioral_response | 2.75836723 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.66326664 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 2.66227675 |
| 12 | MP0002064_seizures | 2.61688750 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.61189131 |
| 14 | MP0009046_muscle_twitch | 2.44673156 |
| 15 | MP0001486_abnormal_startle_reflex | 2.36620152 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.29678286 |
| 17 | MP0002736_abnormal_nociception_after | 2.24140544 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.14051715 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.06241801 |
| 20 | MP0002272_abnormal_nervous_system | 1.80948025 |
| 21 | MP0002184_abnormal_innervation | 1.74103068 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.71368325 |
| 23 | MP0001970_abnormal_pain_threshold | 1.70017884 |
| 24 | MP0003329_amyloid_beta_deposits | 1.69252419 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.66757527 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.65399405 |
| 27 | MP0004924_abnormal_behavior | 1.65399405 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.64768205 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.62853752 |
| 30 | MP0004885_abnormal_endolymph | 1.62592407 |
| 31 | MP0000955_abnormal_spinal_cord | 1.61008028 |
| 32 | MP0002751_abnormal_autonomic_nervous | 1.60253021 |
| 33 | MP0004858_abnormal_nervous_system | 1.57368275 |
| 34 | MP0003879_abnormal_hair_cell | 1.56097165 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.53383840 |
| 36 | MP0003868_abnormal_feces_composition | 1.53238554 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.49950536 |
| 38 | MP0003787_abnormal_imprinting | 1.42332890 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.42078138 |
| 40 | MP0001188_hyperpigmentation | 1.40408228 |
| 41 | MP0003938_abnormal_ear_development | 1.38511781 |
| 42 | MP0008872_abnormal_physiological_respon | 1.37323017 |
| 43 | MP0003122_maternal_imprinting | 1.35801519 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.32484805 |
| 45 | MP0002152_abnormal_brain_morphology | 1.31316058 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.28822868 |
| 47 | MP0004134_abnormal_chest_morphology | 1.27290023 |
| 48 | MP0005187_abnormal_penis_morphology | 1.24436269 |
| 49 | MP0008569_lethality_at_weaning | 1.21386140 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.15137055 |
| 51 | MP0001984_abnormal_olfaction | 1.13180435 |
| 52 | MP0009250_abnormal_appendicular_skeleto | 1.11653296 |
| 53 | MP0003861_abnormal_nervous_system | 1.10514291 |
| 54 | MP0005171_absent_coat_pigmentation | 1.10089681 |
| 55 | MP0003633_abnormal_nervous_system | 1.08096674 |
| 56 | MP0000049_abnormal_middle_ear | 1.06070223 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.05605036 |
| 58 | MP0003283_abnormal_digestive_organ | 1.03814071 |
| 59 | MP0004742_abnormal_vestibular_system | 1.02729958 |
| 60 | MP0003385_abnormal_body_wall | 1.01731430 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.01270998 |
| 62 | MP0003119_abnormal_digestive_system | 1.00384215 |
| 63 | MP0003631_nervous_system_phenotype | 0.99144662 |
| 64 | MP0002102_abnormal_ear_morphology | 0.98790856 |
| 65 | MP0004484_altered_response_of | 0.97688906 |
| 66 | * MP0003755_abnormal_palate_morphology | 0.97516722 |
| 67 | MP0006276_abnormal_autonomic_nervous | 0.96571268 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.95414490 |
| 69 | MP0001905_abnormal_dopamine_level | 0.94831845 |
| 70 | MP0004147_increased_porphyrin_level | 0.94134695 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 0.93811266 |
| 72 | MP0005646_abnormal_pituitary_gland | 0.91704514 |
| 73 | MP0000534_abnormal_ureter_morphology | 0.90714063 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 0.89460138 |
| 75 | MP0006292_abnormal_olfactory_placode | 0.88672998 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.87668329 |
| 77 | MP0000462_abnormal_digestive_system | 0.87558213 |
| 78 | MP0002653_abnormal_ependyma_morphology | 0.86642350 |
| 79 | MP0000427_abnormal_hair_cycle | 0.86484294 |
| 80 | * MP0002116_abnormal_craniofacial_bone | 0.85393079 |
| 81 | MP0002234_abnormal_pharynx_morphology | 0.84732033 |
| 82 | MP0002822_catalepsy | 0.84440017 |
| 83 | MP0004233_abnormal_muscle_weight | 0.82683727 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.81507039 |
| 85 | MP0000026_abnormal_inner_ear | 0.80967434 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.78963945 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.78308880 |
| 88 | MP0005394_taste/olfaction_phenotype | 0.78307814 |
| 89 | MP0005499_abnormal_olfactory_system | 0.78307814 |
| 90 | * MP0002896_abnormal_bone_mineralization | 0.76375502 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.75924545 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.74736089 |
| 93 | MP0003121_genomic_imprinting | 0.74639364 |
| 94 | MP0000516_abnormal_urinary_system | 0.74586784 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.74586784 |
| 96 | * MP0002082_postnatal_lethality | 0.74522572 |
| 97 | * MP0010770_preweaning_lethality | 0.74522572 |
| 98 | * MP0003935_abnormal_craniofacial_develop | 0.74106531 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.73814740 |
| 100 | MP0003045_fibrosis | 0.73504786 |
| 101 | MP0004145_abnormal_muscle_electrophysio | 0.73156479 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.73095348 |
| 103 | MP0004085_abnormal_heartbeat | 0.73020147 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.72043472 |
| 105 | * MP0010769_abnormal_survival | 0.71678151 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.71573646 |
| 107 | MP0001177_atelectasis | 0.71373917 |
| 108 | MP0001529_abnormal_vocalization | 0.71133826 |
| 109 | MP0003632_abnormal_nervous_system | 0.70779696 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.70536621 |
| 111 | * MP0002233_abnormal_nose_morphology | 0.70233413 |
| 112 | MP0001943_abnormal_respiration | 0.69955313 |
| 113 | MP0000647_abnormal_sebaceous_gland | 0.69440166 |
| 114 | * MP0002081_perinatal_lethality | 0.69370271 |
| 115 | MP0001664_abnormal_digestion | 0.69294104 |
| 116 | MP0000538_abnormal_urinary_bladder | 0.68652580 |
| 117 | * MP0000762_abnormal_tongue_morphology | 0.68502500 |
| 118 | * MP0010768_mortality/aging | 0.68480028 |
| 119 | MP0005670_abnormal_white_adipose | 0.67864745 |
| 120 | MP0000920_abnormal_myelination | 0.67802399 |
| 121 | MP0003634_abnormal_glial_cell | 0.66196922 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.65952938 |
| 123 | MP0002168_other_aberrant_phenotype | 0.65680863 |
| 124 | MP0003942_abnormal_urinary_system | 0.65526840 |
| 125 | MP0005503_abnormal_tendon_morphology | 0.65347077 |
| 126 | MP0002971_abnormal_brown_adipose | 0.65223721 |
| 127 | MP0002229_neurodegeneration | 0.61349572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.71065377 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.26252638 |
| 3 | Hyperventilation (HP:0002883) | 5.10163057 |
| 4 | Focal seizures (HP:0007359) | 4.54194717 |
| 5 | Myokymia (HP:0002411) | 4.42743769 |
| 6 | Visual hallucinations (HP:0002367) | 3.70970696 |
| 7 | Atonic seizures (HP:0010819) | 3.63353864 |
| 8 | * Broad-based gait (HP:0002136) | 3.44605416 |
| 9 | Excessive salivation (HP:0003781) | 3.43133335 |
| 10 | Drooling (HP:0002307) | 3.43133335 |
| 11 | Amblyopia (HP:0000646) | 3.16282457 |
| 12 | Genetic anticipation (HP:0003743) | 3.14363187 |
| 13 | Febrile seizures (HP:0002373) | 3.13163142 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.09074201 |
| 15 | Poor eye contact (HP:0000817) | 3.06061631 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.04167126 |
| 17 | Neoplasm of the oral cavity (HP:0100649) | 2.95710872 |
| 18 | Abnormality of the corticospinal tract (HP:0002492) | 2.95081656 |
| 19 | Termporal pattern (HP:0011008) | 2.91727858 |
| 20 | Insidious onset (HP:0003587) | 2.91727858 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 2.89389108 |
| 22 | Absence seizures (HP:0002121) | 2.87232916 |
| 23 | Short chin (HP:0000331) | 2.85740500 |
| 24 | Absent speech (HP:0001344) | 2.82548089 |
| 25 | Mutism (HP:0002300) | 2.78482802 |
| 26 | Dialeptic seizures (HP:0011146) | 2.77493290 |
| 27 | Impaired social interactions (HP:0000735) | 2.74565506 |
| 28 | Abnormal social behavior (HP:0012433) | 2.74565506 |
| 29 | Hepatoblastoma (HP:0002884) | 2.71954310 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.70753425 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.61671450 |
| 32 | Submucous cleft hard palate (HP:0000176) | 2.59399040 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.58072170 |
| 34 | Amyotrophic lateral sclerosis (HP:0007354) | 2.57523818 |
| 35 | Inability to walk (HP:0002540) | 2.55641011 |
| 36 | Inappropriate behavior (HP:0000719) | 2.54523402 |
| 37 | Neurofibrillary tangles (HP:0002185) | 2.49796881 |
| 38 | Heterotopia (HP:0002282) | 2.49073403 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 2.43746290 |
| 40 | Stereotypic behavior (HP:0000733) | 2.43474135 |
| 41 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.38922741 |
| 42 | Short 4th metacarpal (HP:0010044) | 2.38922741 |
| 43 | Midline defect of the nose (HP:0004122) | 2.38707550 |
| 44 | Gaze-evoked nystagmus (HP:0000640) | 2.35365694 |
| 45 | Progressive inability to walk (HP:0002505) | 2.34841554 |
| 46 | Microglossia (HP:0000171) | 2.34424928 |
| 47 | Action tremor (HP:0002345) | 2.32867535 |
| 48 | Shallow orbits (HP:0000586) | 2.31974324 |
| 49 | Akinesia (HP:0002304) | 2.31318298 |
| 50 | Urinary urgency (HP:0000012) | 2.27020878 |
| 51 | Protruding tongue (HP:0010808) | 2.26273772 |
| 52 | Ankle clonus (HP:0011448) | 2.26206625 |
| 53 | Abnormality of salivation (HP:0100755) | 2.26084337 |
| 54 | Lissencephaly (HP:0001339) | 2.25764698 |
| 55 | Large earlobe (HP:0009748) | 2.24331709 |
| 56 | Abnormal eating behavior (HP:0100738) | 2.23326233 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.22420093 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.22251778 |
| 59 | Glioma (HP:0009733) | 2.18319596 |
| 60 | Tented upper lip vermilion (HP:0010804) | 2.15777081 |
| 61 | Meningioma (HP:0002858) | 2.14950153 |
| 62 | Papilledema (HP:0001085) | 2.14637081 |
| 63 | Cupped ear (HP:0000378) | 2.13586274 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.13463217 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.13463217 |
| 66 | Polyphagia (HP:0002591) | 2.13148044 |
| 67 | Abnormality of the labia minora (HP:0012880) | 2.11139307 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.10539144 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.10167391 |
| 70 | Diplopia (HP:0000651) | 2.09486277 |
| 71 | Abnormality of binocular vision (HP:0011514) | 2.09486277 |
| 72 | Dysmetria (HP:0001310) | 2.08975701 |
| 73 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06158258 |
| 74 | Bifid tongue (HP:0010297) | 2.05773717 |
| 75 | Exotropia (HP:0000577) | 2.03434944 |
| 76 | Relative macrocephaly (HP:0004482) | 2.03226205 |
| 77 | Cutaneous finger syndactyly (HP:0010554) | 1.99200177 |
| 78 | Gastroesophageal reflux (HP:0002020) | 1.97988668 |
| 79 | Neoplasm of the adrenal cortex (HP:0100641) | 1.97817198 |
| 80 | Hemiparesis (HP:0001269) | 1.97531543 |
| 81 | Abnormality of the intrinsic pathway (HP:0010989) | 1.97275351 |
| 82 | Megalencephaly (HP:0001355) | 1.97038167 |
| 83 | Prolonged QT interval (HP:0001657) | 1.95858834 |
| 84 | Limb dystonia (HP:0002451) | 1.95289506 |
| 85 | Thickened helices (HP:0000391) | 1.95259311 |
| 86 | Spastic gait (HP:0002064) | 1.92105302 |
| 87 | Blue irides (HP:0000635) | 1.91248508 |
| 88 | Syncope (HP:0001279) | 1.91022900 |
| 89 | Aqueductal stenosis (HP:0002410) | 1.90751928 |
| 90 | Epidermoid cyst (HP:0200040) | 1.90600512 |
| 91 | Metabolic alkalosis (HP:0200114) | 1.89384931 |
| 92 | Open mouth (HP:0000194) | 1.88367721 |
| 93 | Impaired smooth pursuit (HP:0007772) | 1.88006349 |
| 94 | Volvulus (HP:0002580) | 1.87961065 |
| 95 | Sleep apnea (HP:0010535) | 1.87403652 |
| 96 | Widely spaced teeth (HP:0000687) | 1.86785422 |
| 97 | Hyperthyroidism (HP:0000836) | 1.85755546 |
| 98 | Pheochromocytoma (HP:0002666) | 1.84179653 |
| 99 | Fair hair (HP:0002286) | 1.81009263 |
| 100 | Abnormality of the astrocytes (HP:0100707) | 1.79860201 |
| 101 | Astrocytoma (HP:0009592) | 1.79860201 |
| 102 | Intellectual disability, progressive (HP:0006887) | 1.78465632 |
| 103 | Generalized myoclonic seizures (HP:0002123) | 1.77898609 |
| 104 | Dysdiadochokinesis (HP:0002075) | 1.77203646 |
| 105 | Buphthalmos (HP:0000557) | 1.76694362 |
| 106 | Torticollis (HP:0000473) | 1.75857162 |
| 107 | Truncal ataxia (HP:0002078) | 1.74202605 |
| 108 | Facial hemangioma (HP:0000329) | 1.73087144 |
| 109 | Apathy (HP:0000741) | 1.72408691 |
| 110 | Type II lissencephaly (HP:0007260) | 1.72078808 |
| 111 | Abnormal EKG (HP:0003115) | 1.71157332 |
| 112 | Impaired vibratory sensation (HP:0002495) | 1.70551106 |
| 113 | Lower limb muscle weakness (HP:0007340) | 1.70438214 |
| 114 | Polymicrogyria (HP:0002126) | 1.68346100 |
| 115 | Partial agenesis of the corpus callosum (HP:0001338) | 1.68302815 |
| 116 | Intellectual disability, severe (HP:0010864) | 1.68010212 |
| 117 | Tracheomalacia (HP:0002779) | 1.67774347 |
| 118 | Hydroureter (HP:0000072) | 1.67604997 |
| 119 | Short philtrum (HP:0000322) | 1.65977235 |
| 120 | Heterochromia iridis (HP:0001100) | 1.64885599 |
| 121 | Renal cortical cysts (HP:0000803) | 1.64727116 |
| 122 | Colon cancer (HP:0003003) | 1.64650445 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.64294867 |
| 124 | Patellar aplasia (HP:0006443) | 1.63332177 |
| 125 | Abnormality of the lower motor neuron (HP:0002366) | 1.62729933 |
| 126 | Overgrowth (HP:0001548) | 1.62613420 |
| 127 | Increased number of teeth (HP:0011069) | 1.61452949 |
| 128 | Depression (HP:0000716) | 1.60496645 |
| 129 | Benign neoplasm of the central nervous system (HP:0100835) | 1.60038424 |
| 130 | Gait imbalance (HP:0002141) | 1.58713195 |
| 131 | Generalized hypopigmentation of hair (HP:0011358) | 1.58544536 |
| 132 | Clumsiness (HP:0002312) | 1.58488401 |
| 133 | Hypoplasia of the corpus callosum (HP:0002079) | 1.58396995 |
| 134 | Arterial tortuosity (HP:0005116) | 1.58385479 |
| 135 | Muscular hypotonia of the trunk (HP:0008936) | 1.58169517 |
| 136 | Cutaneous syndactyly (HP:0012725) | 1.57618923 |
| 137 | Abnormality of the 4th metacarpal (HP:0010012) | 1.57492907 |
| 138 | Pachygyria (HP:0001302) | 1.57472779 |
| 139 | Hyperactive renin-angiotensin system (HP:0000841) | 1.57448936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.32904067 |
| 2 | CASK | 4.17912152 |
| 3 | EPHA4 | 4.10114975 |
| 4 | FRK | 3.26845638 |
| 5 | MAP3K9 | 3.21620974 |
| 6 | NTRK3 | 2.87212973 |
| 7 | MAP3K4 | 2.85224134 |
| 8 | DAPK2 | 2.76933400 |
| 9 | MAP2K7 | 2.52735638 |
| 10 | PLK2 | 2.27115019 |
| 11 | CDK19 | 2.00992799 |
| 12 | MINK1 | 1.98085738 |
| 13 | CCNB1 | 1.96028331 |
| 14 | PAK6 | 1.89262343 |
| 15 | LATS2 | 1.88546733 |
| 16 | NUAK1 | 1.75861845 |
| 17 | DAPK1 | 1.73082162 |
| 18 | PNCK | 1.71530167 |
| 19 | KSR1 | 1.68822179 |
| 20 | MAPK13 | 1.62927931 |
| 21 | MAP2K4 | 1.54009994 |
| 22 | MAP3K12 | 1.51221942 |
| 23 | NTRK2 | 1.50985831 |
| 24 | OXSR1 | 1.44910277 |
| 25 | DYRK2 | 1.43945422 |
| 26 | AKT3 | 1.39526132 |
| 27 | PINK1 | 1.39290439 |
| 28 | EPHA3 | 1.36982273 |
| 29 | RIPK4 | 1.28262956 |
| 30 | CDK5 | 1.25959433 |
| 31 | CAMKK1 | 1.23509623 |
| 32 | PRPF4B | 1.19018338 |
| 33 | GRK5 | 1.18990432 |
| 34 | KSR2 | 1.15783255 |
| 35 | CDC42BPA | 1.11981140 |
| 36 | SIK2 | 1.08164791 |
| 37 | CSNK1G2 | 1.07346795 |
| 38 | PHKG1 | 1.07306122 |
| 39 | PHKG2 | 1.07306122 |
| 40 | NTRK1 | 1.06078521 |
| 41 | EPHB2 | 1.03912796 |
| 42 | TYRO3 | 1.03692548 |
| 43 | PDGFRA | 1.01772401 |
| 44 | TAOK1 | 1.01247101 |
| 45 | DDR2 | 1.01170919 |
| 46 | TGFBR2 | 0.99593430 |
| 47 | PRKCG | 0.99535184 |
| 48 | ACVR1B | 0.93152204 |
| 49 | FGR | 0.90861207 |
| 50 | CAMK2A | 0.89569928 |
| 51 | CAMK1D | 0.89384173 |
| 52 | CDK18 | 0.86748029 |
| 53 | PKN1 | 0.85435336 |
| 54 | CDK15 | 0.84509895 |
| 55 | DYRK1A | 0.84148893 |
| 56 | STK11 | 0.83495123 |
| 57 | MAP3K6 | 0.83149579 |
| 58 | EIF2AK3 | 0.80951926 |
| 59 | CDK14 | 0.80048133 |
| 60 | PRKD3 | 0.79018545 |
| 61 | ICK | 0.77324529 |
| 62 | MKNK2 | 0.76758215 |
| 63 | CAMK4 | 0.74873224 |
| 64 | PAK3 | 0.74213362 |
| 65 | CAMK2B | 0.73796466 |
| 66 | CAMKK2 | 0.73685285 |
| 67 | ERBB3 | 0.73415658 |
| 68 | PIK3CA | 0.73034191 |
| 69 | CDK11A | 0.72656175 |
| 70 | PTK2B | 0.72177376 |
| 71 | CDK3 | 0.71830503 |
| 72 | TNIK | 0.70700147 |
| 73 | ROCK1 | 0.69608466 |
| 74 | WNK1 | 0.68431256 |
| 75 | MARK2 | 0.67649998 |
| 76 | TAOK3 | 0.67562348 |
| 77 | MET | 0.64394736 |
| 78 | UHMK1 | 0.64255224 |
| 79 | SGK223 | 0.63402804 |
| 80 | SGK494 | 0.63402804 |
| 81 | LIMK1 | 0.61257050 |
| 82 | MAPK12 | 0.60994802 |
| 83 | SGK1 | 0.60036834 |
| 84 | CAMK1G | 0.55791632 |
| 85 | CSNK1A1L | 0.55139108 |
| 86 | RAF1 | 0.54537003 |
| 87 | PRKCE | 0.53839927 |
| 88 | BMPR2 | 0.52818172 |
| 89 | LMTK2 | 0.52639101 |
| 90 | STK38 | 0.52026575 |
| 91 | WNK3 | 0.52017524 |
| 92 | PRKCZ | 0.51421533 |
| 93 | MAP3K2 | 0.50347333 |
| 94 | ARAF | 0.50025936 |
| 95 | RET | 0.49313113 |
| 96 | DAPK3 | 0.49042501 |
| 97 | ILK | 0.48362733 |
| 98 | BCR | 0.48054379 |
| 99 | MST1R | 0.47018549 |
| 100 | PDGFRB | 0.46988620 |
| 101 | DMPK | 0.46701069 |
| 102 | CSNK1G3 | 0.45940122 |
| 103 | CAMK1 | 0.44841447 |
| 104 | FGFR2 | 0.44055637 |
| 105 | EIF2AK1 | 0.43631224 |
| 106 | ALK | 0.43559247 |
| 107 | SGK2 | 0.42482738 |
| 108 | PRKDC | 0.41455671 |
| 109 | CSNK1E | 0.41368161 |
| 110 | TRPM7 | 0.41196158 |
| 111 | MAPK7 | 0.41031957 |
| 112 | CSNK1G1 | 0.40485634 |
| 113 | PRKCI | 0.40159712 |
| 114 | PLK3 | 0.39169974 |
| 115 | TRIM28 | 0.38890229 |
| 116 | WNK4 | 0.38293768 |
| 117 | LATS1 | 0.37976838 |
| 118 | FYN | 0.37490816 |
| 119 | GSK3B | 0.37128288 |
| 120 | PDPK1 | 0.37013935 |
| 121 | STK39 | 0.36886544 |
| 122 | NME1 | 0.36143301 |
| 123 | ERBB2 | 0.35668729 |
| 124 | GRK1 | 0.34424764 |
| 125 | ROCK2 | 0.34056654 |
| 126 | PRKCB | 0.33499865 |
| 127 | BMPR1B | 0.33233224 |
| 128 | CSNK1A1 | 0.32061203 |
| 129 | CAMK2D | 0.31823575 |
| 130 | GRK6 | 0.30813109 |
| 131 | INSRR | 0.30802077 |
| 132 | SGK3 | 0.30005439 |
| 133 | ADRBK1 | 0.29843405 |
| 134 | RPS6KA3 | 0.29445321 |
| 135 | YES1 | 0.28488944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.25285281 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.98018308 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.53000509 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50241551 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.45350486 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42484433 |
| 7 | Axon guidance_Homo sapiens_hsa04360 | 2.28856414 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27401237 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.18267761 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.14358182 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.11834480 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09483574 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05656778 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88252443 |
| 15 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.84892316 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.84687258 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.82039393 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74397246 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.73586983 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.70978638 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70503222 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63411247 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60991789 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.60548235 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57631038 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.53255488 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.52940719 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51640606 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46451196 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38103055 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36027270 |
| 32 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.35158945 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34644657 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.27275012 |
| 35 | Melanogenesis_Homo sapiens_hsa04916 | 1.24069617 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.24002250 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22701110 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17272678 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15203211 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14178276 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13668172 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07687438 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.07682282 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05068915 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05016266 |
| 46 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.04216377 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01805121 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00145994 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00069534 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.99966951 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.98318148 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.93470993 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92049436 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91763529 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91755958 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91009675 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90922585 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90603197 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87488720 |
| 60 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.87118447 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86806875 |
| 62 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83595715 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82152330 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80140649 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79769699 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79711964 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.79024473 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78590681 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76516357 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.76347000 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74696434 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73789803 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73739224 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71989241 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71392620 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69312294 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67955028 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67366262 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.67023456 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66572181 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65449691 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64378760 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63519107 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62518297 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61415593 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60519833 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59956485 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.59658664 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59393611 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59154315 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58936525 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58607506 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58483902 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56761574 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56113228 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.55769577 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55036330 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53833584 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53185753 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52988583 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52247575 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50178079 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.49876627 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49462291 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.49397974 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48006051 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47866454 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47082396 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.46627674 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46164531 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.45824940 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45123977 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45093853 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44419683 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43742256 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38664873 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38359997 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38219989 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.37760282 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.34983465 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34651583 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34597752 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33521467 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33017542 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32287167 |

